22k
3.6k
Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

Earnings per share for GSK Pharmaceuticals Limited in India 2013-2018

Earnings per share (EPS) GSK Pharmaceuticals Limited in India from 2013 to 2018 (in Indian rupees)

by Statista Research Department, last edited Apr 24, 2019
Earnings per share for GSK Pharmaceuticals Limited in India 2013-2018 This statistic shows the Earnings Per Share (EPS) of Glaxo Smith Kline Pharmaceuticals Limited in India from calendar year 2013 to financial year 2018. The EPS for fiscal year 2018 was 41.6 Indian rupees, higher than in the previous year.
Show more

Earnings per share (EPS) GSK Pharmaceuticals Limited in India from 2013 to 2018 (in Indian rupees)

Value in Indian rupees
--
--
--
--
--
Value in Indian rupees
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account
only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account
only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

© Statista 2019

About this statistic

Show source

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Apr 24, 2019
This statistic shows the Earnings Per Share (EPS) of Glaxo Smith Kline Pharmaceuticals Limited in India from calendar year 2013 to financial year 2018. The EPS for fiscal year 2018 was 41.6 Indian rupees, higher than in the previous year.
Show more

Other statistics on the topic

Revenue of top 20 respiratory brands in the U.S. 2016

Revenue of top 20 respiratory brands in the U.S. 2016

U.S. top 20 prescribed drugs based on sales 2016

U.S. top 20 prescribed drugs based on sales 2016

GSK: revenue of Seretide/Advair globally by region 2012-2018

GSK: revenue of Seretide/Advair globally by region 2012-2018

Top U.S. pharma products by prescriptions 2016

Top U.S. pharma products by prescriptions 2016

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical brands: Advair/Seretide (GlaxoSmithKline)"
  • Overview
The most important statistics
  • Drug prices and consumer behavior
  • Advertising expenditures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
Topics
Market Analytics
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Menu